CryoLife: CryoLife Reports Third Quarter 2021 Financial Results
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today its financial results for the third quarter ended September 30, 2021.
Read full article »
CryoLife is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications.
Read more